Closing arguments begin in Johnson & Johnson Risperdal trial in Arkansas

Closing arguments are under way in Arkansas' billion-dollar lawsuit against a Johnson & Johnson subsidiary that makes the antipsychotic drug Risperdal.

By: Chuck Bartels, Associated Press, Superior Telegram